David A. Bellnier

4.7k total citations
82 papers, 3.9k citations indexed

About

David A. Bellnier is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, David A. Bellnier has authored 82 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 47 papers in Biomedical Engineering and 16 papers in Materials Chemistry. Recurrent topics in David A. Bellnier's work include Photodynamic Therapy Research Studies (70 papers), Nanoplatforms for cancer theranostics (44 papers) and Porphyrin and Phthalocyanine Chemistry (16 papers). David A. Bellnier is often cited by papers focused on Photodynamic Therapy Research Studies (70 papers), Nanoplatforms for cancer theranostics (44 papers) and Porphyrin and Phthalocyanine Chemistry (16 papers). David A. Bellnier collaborates with scholars based in United States, Hungary and Austria. David A. Bellnier's co-authors include Thomas J. Dougherty, Barbara W. Henderson, Ravindra K. Pandey, William R. Greco, Allan R. Oseroff, Lurine A. Vaughan, William R. Potter, Joseph R. Missert, Gregory Loewen and Gal Shafirstein and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and Journal of neurosurgery.

In The Last Decade

David A. Bellnier

81 papers receiving 3.8k citations

Peers

David A. Bellnier

PRM

K. R. Weishaupt United States

William R. Potter United States

Scott L. Gibson United States

Kathryn W. Woodburn United States

Magne Kongshaug Norway

Tadanobu Nagaya United States

Lurine A. Vaughan United States

Shun‐ichiro Ogura Japan

Irina V. Balalaeva Russia

Lina Bezdetnaya France

K. R. Weishaupt United States

David A. Bellnier

3.0k ×1.0

PRM

1.8k ×0.7

1.2k ×0.9

1.0k ×1.3

384 ×0.8

Citations per year, relative to David A. Bellnier David A. Bellnier (= 1×) peers K. R. Weishaupt

Countries citing papers authored by David A. Bellnier

Since Specialization

Citations

This map shows the geographic impact of David A. Bellnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Bellnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Bellnier more than expected).

Fields of papers citing papers by David A. Bellnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Bellnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Bellnier. The network helps show where David A. Bellnier may publish in the future.

Co-authorship network of co-authors of David A. Bellnier

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Bellnier. A scholar is included among the top collaborators of David A. Bellnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Bellnier. David A. Bellnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chamberlain, Sarah, et al.. (2020). TLD1433-Mediated Photodynamic Therapy with an Optical Surface Applicator in the Treatment of Lung Cancer Cells In Vitro. Pharmaceuticals. 13(7). 137–137. 38 indexed citations

Shafirstein, Gal, David A. Bellnier, Alan D. Hutson, et al.. (2018). Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer. British Journal of Cancer. 119(10). 1191–1199. 38 indexed citations

Pera, Paula, et al.. (2018). Photodynamic therapy does not induce cyclobutane pyrimidine dimers in the presence of melanin. Photodiagnosis and Photodynamic Therapy. 22. 241–244. 7 indexed citations

Harris, Kassem, et al.. (2017). Endobronchial ultrasound—guidance for interstitial photodynamic therapy of locally advanced lung cancer—a new interventional concept. Journal of Thoracic Disease. 9(8). 2613–2618. 10 indexed citations

Zeitouni, Nathalie C., Ulaş Sunar, Daniel Rohrbach, et al.. (2014). A Prospective Study of Pain Control by a 2-Step Irradiance Schedule During Topical Photodynamic Therapy of Nonmelanoma Skin Cancer. Dermatologic Surgery. 40(12). 1390–1394. 18 indexed citations

Rigual, Nestor, et al.. (2014). Image-guided interstitial photodynamic therapy for squamous cell carcinomas: Preclinical investigation. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 27(2). 159–165. 9 indexed citations

Sunar, Ulaş, et al.. (2011). Aminolevulinic Acid‐Photodynamic Therapy Combined with Topically Applied Vascular Disrupting Agent Vadimezan Leads to Enhanced Antitumor Responses. Photochemistry and Photobiology. 87(4). 910–919. 12 indexed citations

Seshadri, Mukund & David A. Bellnier. (2008). The Vascular Disrupting Agent 5,6‐Dimethylxanthenone‐4‐Acetic Acid Improves the Antitumor Efficacy and Shortens Treatment Time Associated with Photochlor‐sensitized Photodynamic Therapy In Vivo. Photochemistry and Photobiology. 85(1). 50–56. 19 indexed citations

Seshadri, Mukund, Joseph A. Spernyak, Patricia Maier, et al.. (2007). Visualizing the Acute Effects of Vascular-Targeted Therapy In Vivo Using Intravital Microscopy and Magnetic Resonance Imaging: Correlation with Endothelial Apoptosis, Cytokine Induction, and Treatment Outcome. Neoplasia. 9(2). 128–135. 35 indexed citations

10.

Henderson, Barbara W. & David A. Bellnier. (2007). Tissue Localization of Photosensitizers and the Mechanism of Photodynamic Tissue Destruction. Novartis Foundation symposium. 146. 112–130. 16 indexed citations

11.

Oseroff, Allan R., B. Dale Wilson, Thomas S. Mang, et al.. (2006). A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma. Lasers in Surgery and Medicine. 38(5). 417–426. 39 indexed citations

12.

Bellnier, David A., William R. Greco, Hector Nava, et al.. (2005). Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemotherapy and Pharmacology. 57(1). 40–45. 88 indexed citations

13.

Bellnier, David A., William R. Greco, Gregory Loewen, et al.. (2003). Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.. PubMed. 63(8). 1806–13. 112 indexed citations

14.

Henderson, Barbara W., Theresa M. Busch, Lurine A. Vaughan, et al.. (2000). Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.. PubMed. 60(3). 525–9. 228 indexed citations

15.

Nava, Hector, James Smith, H. O. Douglass, et al.. (2000). Preliminary clinical data on a new photodynamic therapy photosensitizer, 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a(HPPH) for treatment of obstructive esophageal cancer.. Proc SPIE. 3909. 25–27. 10 indexed citations

16.

Bernstein, Zale P., B. Dale Wilson, Allan R. Oseroff, et al.. (1999). Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi‚s sarcoma. AIDS. 13(13). 1697–1704. 28 indexed citations

17.

MacDonald, Ian J., Janet Morgan, David A. Bellnier, et al.. (1999). Subcellular Localization Patterns and Their Relationship to Photodynamic Activity of Pyropheophorbide-a Derivatives. Photochemistry and Photobiology. 70(5). 789–789. 98 indexed citations

18.

Henderson, Barbara W., et al.. (1995). PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN. Photochemistry and Photobiology. 62(4). 780–789. 70 indexed citations

19.

Bellnier, David A. & Thomas J. Dougherty. (1986). Haematoporphyrin Derivative Photosensitization and γ-radiation Damage Interaction in Chinese Hamster Ovary Fibroblasts. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 50(4). 659–664. 26 indexed citations

20.

Bellnier, David A., et al.. (1983). Photodynamic destruction of cultured human bladder tumor cells by hematoporphyrin derivative: effects of porphyrin molecular aggregation. Photobiochemistry and photobiophysics.. 6(5-6). 357–366. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact